Filing Flows › 60 Degrees Pharmaceuticals (SXTP) › Stock forecast & fair value
60 Degrees Pharmaceuticals (SXTP) stock forecast and price target
60 Degrees Pharmaceuticals (SXTP) trades at $0.59. One analyst's price target is $3.70 (+522%).
60 Degrees Pharmaceuticals' latest quarter
60 Degrees Pharmaceuticals, Q2 2026: revenue $208K (+106% year over year), net loss $2.3M, operating cash flow −$2.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for SXTP stock?
One analyst's 12-month target is $3.70, +522% from $0.59. The average rating is none.
Does 60 Degrees Pharmaceuticals usually beat earnings estimates?
It beat the consensus EPS estimate in 25% of the quarters on record.
Is SXTP stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.